Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised
- Author
- Stephen Cantrill MD FACEP, Rajesh T. Gandhi MD, Payal K. Patel MD MPH FIDSA
- Published
- Mon 10 Mar 2025
- Episode Link
- https://idpodcast.simplecast.com/episodes/covid-rounds-us-episode-4-Fo1K89HI
In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including:
- Antiviral therapy with remdesivir
- Dexamethasone and other systemic corticosteroids
- Immunomodulators, such as JAK inhibitors or IL-6 inhibitors
- Overviews of clinical trial data demonstrating how and when to use these therapies
Presenters:
Stephen Cantrill, MD, FACEP
Associate Director and Medical Director (Retired)
Department of Emergency Medicine
Denver Health Medical Center
Associate Professor
Department of Emergency Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Rajesh T. Gandhi, MD
Massachusetts General Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Payal K. Patel, MD, MPH, FIDSA
Systemwide Director of Antimicrobial Stewardship
Associate Professor, Division of Infectious Diseases
Intermountain Health
Salt Lake City, Utah
Link to full program:
https://bit.ly/4gu2gcU
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
